Adenosine A(2A) receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

European Journal of Pharmacology

Volumn 321, Issue 2, 1997, Pages 143-147

  Fenu, Sandro ^a   Pinna, Annalisa ^a   Ongini, Ennio ^b   Morelli, Micaela ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Schering Plough Research Institute   (Italy)

Author keywords

Dopamine D1 receptor; Dopamine D2 receptor; Early gene; L DOPA (3,4 dihydroxyphenyl L alanine); Parkinson's disease; Striatum

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; LEVODOPA; OXIDOPAMINE; QUINPIROLE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PROTEIN C FOS; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENTIATION; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; BRAIN DISEASE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; ONCOGENE; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN DISEASES; DOPAMINE AGONISTS; DRUG SYNERGISM; GENE EXPRESSION; GENES, FOS; LEVODOPA; MALE; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; PYRIMIDINES; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1; SUBSTANTIA NIGRA; TRIAZOLES;

EID: 0030615062     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00944-2     Document Type: Article

References (27)

1. Casas, M., S. Ferré, A. Cobos, J.N. Grau and F. Jane, 1989, Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway, Neuropharmacology 28, 407.
2. 2 receptors in the neostriatum, Brain Res. 594, 124.
3. Ferré, S., K. Fuxe, G. Von Euler, B. Johansson and B.B. Fredholm, 1992, Adenosine-dopamine interactions in the brain, Neuroscience 51, 501.
4. 2 dopamine receptors in rat striatum, Mol. Brain Res. 14, 186.
5. Fredholm, B.B., M. Herrera-Marschitz, B. Jonzon, K. Lindström and U. Ungerstedt, 1983, On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat, Pharmacol. Biochem. Behav. 19, 535.
6. Fredholm, B.B., M.P. Abbracchio, G. Burnstook, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff and M. Williams, 1994, VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143.
7. Fuxe, K. and U. Ungerstedt, 1974, Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with dopa and dopamine receptor agonists, Med. Biol. 52, 48.
8. Garrett, B.E. and S.G. Holtzman, 1995, Does adenosine receptor blockade mediate caffeine-induced rotational behavior?, J. Pharmacol. Exp. Ther. 274, 207.
9. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science 250, 1429.
10. Herrera-Marschitz, M., M. Casas and U. Ungerstedt, 1988, Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses, Psychopharmacology 94, 38.
11. 3H]CGS 21680, Eur. J. Pharmacol. 168, 243.
12. Jiang, H., V. Jackson-Lewis, U. Muthane, A. Dollison, M. Ferreira, A. Espinosa, B. Parsons and S. Przedborski, 1993, Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats, Brain Res. 613, 347.
13. Kartzinel, R., I. Shoulson and D.B. Calne, 1976, Studies with bromocriptine. III. Concomitant administration of caffeine to patients with idiopathic parkinsonism, Neurology 26, 741.
14. 1 dopamine receptor gene, Proc. Natl. Acad. Sci. USA 88, 4205.
15. Mally, J. and T.W. Stone, 1995, Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propanolol, J. Neurol. Sci. 132, 129.
16. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats, Eur. J. Pharmacol. 251, 21.
17. 2A receptors, Trends Pharmacol. Sci. 17, 364.
18. Pazzagli, M., C. Corsi, S. Latini, F. Pedata and G. Pepeu, 1994, In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors, Eur. J. Pharmacol. 254, 277.
19. Pellegrino, L.J., A.S. Pellegrino and A.J. Cushman, 1979, A Stereotaxic Atlas of the Rat Brain (Plenum Press, New York, NY).
20. 2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats, Eur. J. Neurosci. 8, 1176.
21. 2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats, Eur. J. Pharmacol. 257, 21.
22. Sagar, S., F.R. Sharp and Y. Curran, 1988, Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science 240, 1328.
23. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons, J. Neurosci. 13, 1080.
24. Shoulson, I. and T. Chase, 1975, Caffeine and the antiparkinsonian response to levodopa or piribedil, Neurology 25, 722.
25. Ungerstedt, U., 1971, Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigrostriatal dopamine system, Acta Physiol. Scand. 367, 69.
26. 2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation, Psychopharmacology 111, 383.
27. 2a adenosine receptor antagonist, J. Pharmacol. Exp. Ther. 276, 389.